All Pharma News
NMPA Approves Chidamide+R-CHOP For Diffuse Large B-Cell Lymphoma

NMPA Approves Chidamide+R-CHOP For Diffuse Large B-Cell Lymphoma
PR NEWSWIRE
30 Apr 2024
Share Share
Positive results from Phase II clinical trial of Chiglitazar monotherapy

Positive results from Phase II clinical trial of Chiglitazar monotherapy
PR NEWSWIRE
18 Mar 2024
Share Share
Chipscreen`s New Drug Candidate CS32582 Capsules Approved for Psoriasis

Chipscreen`s New Drug Candidate CS32582 Capsules Approved for Psoriasis
PR NEWSWIRE
02 Nov 2023
Share Share
Chipscreen bags Chinese rights to Biocytogen`s Keytruda killer

Chipscreen bags Chinese rights to Biocytogen`s Keytruda killer
Nick Paul Taylor FIERCE BIOTECH
27 Feb 2023
Share Share
Chipscreen Biosciences Announces NMPA New Drug Approval of Bilessglu®

Chipscreen Biosciences Announces NMPA New Drug Approval of Bilessglu®
PRNEWSWIRE
19 Oct 2021
Share Share
Chipscreen received a Phase 1b/2 clinical trial of Chiauranib/CS2164 IND

Chipscreen received a Phase 1b/2 clinical trial of Chiauranib/CS2164 IND
BIOSPACE
16 Apr 2021
Share Share
Chipscreen and HISUN reach a strategic cooperation

Chipscreen and HISUN reach a strategic cooperation
PRNEWSWIRE
16 Dec 2020
Share Share
Chipscreen and HISUN reach a strategic cooperation

Chipscreen and HISUN reach a strategic cooperation
PRNEWSWIRE
16 Dec 2020
Share Share
Chipscreen Biosciences`s Original New Drug CS12192: (IND) Application Accepted

Chipscreen Biosciences`s Original New Drug CS12192: (IND) Application Accepted
PR NEWSWIRE
24 Mar 2020
Share Share
NMPA Approves Chipscreen Bioscience`s Chidamide for Breast Cancer Indication

NMPA Approves Chipscreen Bioscience`s Chidamide for Breast Cancer Indication
PR NEWSWIRE
30 Nov 2019
Share Share